Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Calyx Chemicals & Pharmaceuticals Limited
FDA Inspection
•Calyx Chemicals & Pharmaceuticals Limited•May 17, 2024

Calyx Chemicals & Pharmaceuticals Limited – FDA Inspection, May 17, 2024

Record Details

This FDA Inspection record concerns Calyx Chemicals & Pharmaceuticals Limited, with an inspection on May 17, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Calyx Chemicals & Pharmaceuticals Limited
Inspection Date
May 17, 2024
Product Type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Guerlain Ulysse (FDA Associated Person)
  • Yvins Dezan
View Company Profile

ID · 0e4db988-4bbb-42d5-a17d-9901226c1dca

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number
1240456
FDA center
Human Drugs
Project area
Drug Quality Assurance

Other FDA inspections of Calyx Chemicals & Pharmaceuticals Limited

4
DateClassificationOfficeProject area
November 8, 2019VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
March 4, 2016VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
March 27, 2012VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
September 18, 2009VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
Other documents for Calyx Chemicals & Pharmaceuticals Limited
  • FDA Inspection 1110153 - 2019-11-08
  • FDA Inspection 967429 - 2016-03-04
  • FDA Inspection 775620 - 2012-03-27
  • FDA Inspection 641001 - 2009-09-18

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Calyx Chemicals & Pharmaceuticals Limited
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.